CXCL8 and breast neoplasm: Thus, hyper-activated RasG12V cooperated with inflammatory factors that were shown to be prevalent at the breast tumor microenvironment [21], together potentiating the release of the powerful angiogenic and tumor-promoting chemokine CXCL8 by the tumor cells.